Search Existing Data Requests

The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.


Search Terms:


Investigator: hugo vanderstichele

Project Title: CSF Biomarker analysis for to the Adult Children Study (ACS) of the Knight Alzheimer�s Disease Research Center at Washington (recently published by JAMA NEUROLOGY)

Date: December 21, 2021 at 5:18 pm

Request ID: D1510

Aim 1: AD CSF biomarker changes in cognitively normal middle-aged adults

Aim 2: Performance of individual biomarkers or combinations of biomarkers

Aim 3: Comparison of biomarkers with imaging data

Aim 4: Evaluate correlation between CSF biomarkers and cognitive performance


Investigator: John C. Morris

Project Title: Examining the Relationship Between Depressive Symptoms and Cognitive Deficits in Preclinical Dementia of the Alzheimer Type

Date: December 21, 2021 at 5:18 pm

Request ID: D1511

Aim 1: Examine results from a psychometric battery of cognitive tests for patients with no evidience of clinical dementia

Aim 2: Asses the relationship between depression and preclinical AD through CSF samples analyzed for AD markers and PIB-PET amyloid imaging.

Aim 3: Compare antidepressive medication usage (e.g. SSRIs) to imaging data to assess the effect of medication usage on amyloid buildup.

Aim 4: To understand if those with depression and higher amyloid burden have worse cognitive performance.


Investigator: Brian Gordon

Project Title: Sleep effects on amyloid deposition in preclinical AD

Date: December 21, 2021 at 5:18 pm

Request ID: D1512

Aim 1: Sleep quantity and quality to levels of amyloid deposition measured with PET and may be associated with structural atrophy

Aim 2: Sleep measures will predict baseline performance on psychometric testing

Aim 3: Use baseline measures of sleep will predict longitudinal amyloid, atrophy, and cognition

Aim 4:


Investigator: GS Day

Project Title: Evaluating the impact of medications in Alzheimer disease

Date: December 21, 2021 at 5:18 pm

Request ID: D1513

Aim 1: 1. Determine whether medications previously associated with cognitive impairment (i.e., offending medications) in cognitively normal individuals, associate with cognitive impairment in Memory and Aging Participants.

Aim 2: 2. Calculate the magnitude of effect of offending medication on participants with normal cognition, preclinical Alzheimer disease (AD) and symptomatic AD.

Aim 3:

Aim 4:


Investigator: Zehra Onen

Project Title: Optimal Population Screening Policies for Alzheimer’s Disease

Date: December 21, 2021 at 5:18 pm

Request ID: D1514

Aim 1: To compute optimal population screening policies for Alzheimer�s Disease (AD) using Markov Decision Process (MDP) and Partially Observable MDP models.

Aim 2: To compute annual transition probabilities within AD free and preclinical stage individuals

Aim 3: To build mathematical models for biomarkers’ progression focusing on normal individuals and individuals in preclinical stages of Alzheimer’s Disease

Aim 4:


Investigator: Angela Curl

Project Title: Psychometric Testing of the CARS Instrument

Date: December 21, 2021 at 5:18 pm

Request ID:

Aim 1: To test the psychometric reliability of the newly developed CARS Instrument

Aim 2: To test the psychometric validity of the newly developed CARS Instrument

Aim 3:

Aim 4:


Investigator: Kirchhoff

Project Title: An Investigation of the Relationships Between Brain Structure and Attentional Control

Date: December 21, 2021 at 5:18 pm

Request ID: D1516

Aim 1: To identify brain regions that support successful attentional control processes by examining the relationships between brain structure and performance on attentional control tasks.

Aim 2: To investigate the brain structural changes that lead to attentional control impairments in Alzheimer�s Disease.

Aim 3: To examine whether brain structure at least partially mediates the relationships between AD risk and attentional control.

Aim 4:


Investigator: Lenise Cummings-Vaughn

Project Title: Exploring AD Biomarker Disparities Between African Americans and European Americans

Date: December 21, 2021 at 5:18 pm

Request ID: D1517

Aim 1: Determine whether Alzhemer Disease (AD) biomarker abnormalities vary as a function of race or ethnicity

Aim 2: Determine if African Americans with preclinical AD have a higher frequency of cerebrovascular lesions.

Aim 3: Determine if African Americans with preclinical AD have higher frequency of hypovitaminosis D.

Aim 4: Determine if African Americans with preclinical AD have a higher frequency of chronic inflammation.


Investigator: Beau Ances

Project Title: The Influence of Traumatic Brain Injury on Anatomical Morphometry in Alzheimer’s Disease

Date: December 21, 2021 at 5:18 pm

Request ID: D1518

Aim 1: Are hippocampal volumes different cross-sectionally between AD patients with and without the presence of a TBI and LOC?

Aim 2: Is the degenerative component for AD patients with a TBI and LOC

Aim 3: Longitudinally, is the AD progression more drastic in patients who experienced a TBI with LOC compared to AD patients without a TBI

Aim 4:


Investigator: Sebastien Ourselin

Project Title: Validation of attenuation correction synthesis for PET-MR scanners

Date: December 21, 2021 at 5:18 pm

Request ID: D1519

Aim 1: Validate a novel method of attenuation correction for PET-MR data by creating “pseudo-CT” images that are created based on information provided from a template library of co-registered MR and CT pairs.

Aim 2:

Aim 3:

Aim 4: